glp-1 depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Unpacking the Data on GLP-1

doi: 10.1001/jamaneurol.2014.131 208 SeetRC-SLimECHTanJJHQuekAMLChowAWLChongW-Let al

However, to our knowledge, there are a limited number of human studies that have examined the effect of riboflavin on reduced glutathione status

In a study of overweight and obese patients with asthma, an exercise intervention led to a reduction in eosinophilic airway inflammation, even though there was only modest weight loss [75]

While most effects are transient, a significant subset of patients develop persistent intolerance, often leading to misdiagnosis, unnecessary investigations, or premature treatment discontinuation

Bridging neurotrophic factors and bioactive peptides to Alzheimers disease